DIANA PUKHOVICH: Open Payments
NPI 1437891199 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 63 payments from 15 companies in 2025. Trend: 2023 $473 · 2024 $1,236 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $317 |
| Eisai Inc. | 5 | $233 |
| VERTEX PHARMACEUTICALS INCORPORATED | 7 | $185 |
| Boston Scientific Corporation | 1 | $150 |
| ABBVIE INC. | 7 | $139 |
| Valinor Pharma, LLC | 8 | $136 |
| SCILEX PHARMACEUTICALS INC. | 7 | $131 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Indivior Inc. | 3 | $65 |
| Biogen, Inc. | 2 | $49 |
Products named: RELISTOR, Leqembi, JOURNAVX, General - Therapies, MOVANTIK, ZTLido, Symbravo, QULIPTA.
Industry payments across NY — which companies pay providers there.
